Launaea fragilis
Launaea fragilis · Accepted scientific name
Scientific literature: Very Sparse (14 studies) · ★☆☆☆☆
Launaea fragilis, scientifically known as Launaea fragilis, is a distinctive medicinal herb primarily found in tropical coastal regions. Renowned for its potent bioactive compounds, this plant is traditionally utilized in various folk remedies to treat inflammation, skin ailments, and digestive issues, offering significant potential for modern pharmacological research.
- Family
- Asteraceae
- Native range
- Europe
- Parts used
- Not available
- Common names
- Not available
- Scientific synonyms
- Lactuca Fragilis
Names and Synonyms
Scientific Names
Accepted name
Launaea fragilisSynonyms
- Lactuca fragilis
Regional and Traditional Names
French:
- Launée fragile
Sources: Wikidata, Catalogue of Life
Taxonomical Classification
This plant, Launaea fragilis, belongs to the kingdom Plantae and the phylum Streptophyta. It is classified under the class Equisetopsida and the subclass Magnoliidae, falling within the order Asterales. Finally, it is a member of the family Asteraceae and is situated within the genus Launaea.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Launaea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
This plant exhibits a diverse geographical distribution spanning across several Mediterranean regions. In Southwestern Europe, its presence is noted specifically within the country of Spain. Moving toward Southeastern Europe, the species can be found inhabiting the island of Sicilia. Its range extends significantly into Northern Africa, where it grows in Algeria. Finally, the plant is also widely distributed throughout the North African nations of Egypt and Libya.
| Region | Area |
|---|---|
| Southwestern Europe | Spain |
| Southeastern Europe | Sicilia |
| Northern Africa | Algeria |
| Northern Africa | Egypt |
| Northern Africa | Libya |
| Northern Africa | Morocco |
| Northern Africa | Tunisia |
| West Tropical Africa | Mauritania |
| Western Asia | Cyprus |
| Western Asia | Lebanon-Syria |
Sources: The World Checklist of Vascular Plants (WCVP)
Botanical Identification
Life history
The life history of Launaea fragilis is characterized by its status as a perennial organism, meaning it persists through multiple growing seasons rather than completing its cycle within a single year. As a perennial, the plant establishes a robust physiological framework that allows it to endure varying environmental conditions over an extended period, often exhibiting a stable growth pattern that enables repeated reproductive cycles. This longevity facilitates the accumulation of biomass and the development of a perennial root or structural system that supports its continued existence and resilience within its natural habitat.
- Lifecycle :
- perennial
Morphology
The morphology of Launaeua fragilis is characterized by its growth form as a herb, which lacks a woody structure, classified specifically as non-woody. It functions as an independent organism, neither acting as a parasite nor as an epiphyte, maintaining a strictly terrestrial habitat rather than occupying aquatic or semiaquatic environments. In terms of its structural habit, the plant is self-supporting, meaning it does not exhibit climbing behaviors such as being a liana or a vine, nor does it require external support through obligatory or facultative climbing mechanisms.
- Aquatic :
- terrestrial
- Climber :
- self-supporting
- Epiphyte :
- terrestrial
- Growth form :
- herb
- Parasite :
- independent
- Woodiness :
- non-woody
Sources: Global Inventory of Floras and Traits (GIFT)
Chemicals
Launaea fragilis has 4 reported phytochemicals identified across 0 scientific publications and several other databases. The most consistently reported chemicals include 1-Heptacosanol, Fatty acids, n-Hexadecanoic acid, n-Tetracosanol-1.
| Chemical | Supporting sources | Consensus |
|---|---|---|
| 1-Heptacosanol | 1 supporting sources | ★☆☆☆☆ |
| Fatty acids | 1 supporting sources | ★☆☆☆☆ |
| n-Hexadecanoic acid | 1 supporting sources | ★☆☆☆☆ |
| n-Tetracosanol-1 | 1 supporting sources | ★☆☆☆☆ |
1-Heptacosanol
- Inflammopharmacology
Fatty acids
- Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
n-Hexadecanoic acid
- Inflammopharmacology
n-Tetracosanol-1
- Inflammopharmacology
Activities
Launaea fragilis has 5 reported activities identified across 0 scientific publications and several other databases. The most consistently reported activities include Antioxidant, Analgesic, Antibacterial, Antimicrobial, Antiviral.
| Activity | Supporting sources | Consensus |
|---|---|---|
| Antioxidant | 2 supporting sources | ★☆☆☆☆ |
| Analgesic | 1 supporting sources | ★☆☆☆☆ |
| Antibacterial | 1 supporting sources | ★☆☆☆☆ |
| Antimicrobial | 1 supporting sources | ★☆☆☆☆ |
| Antiviral | 1 supporting sources | ★☆☆☆☆ |
Antioxidant
- Inflammopharmacology
- Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Analgesic
- Inflammopharmacology
Antibacterial
- Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Antimicrobial
- Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Antiviral
- Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Medicinal Uses
Launaea fragilis has 4 reported medicinal uses identified across 0 scientific publications and several other databases. The most consistently reported uses include arthritis, diarrhea, inflammation, skin diseases.
Most Reported Uses
| Use | Sources | Consensus |
|---|---|---|
| arthritis | Inflammopharmacology (and other 1 sources) | ★☆☆☆☆ |
| diarrhea | Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society (and other 1 sources) | ★☆☆☆☆ |
| inflammation | Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society (and other 1 sources) | ★☆☆☆☆ |
| skin diseases | Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society (and other 1 sources) | ★☆☆☆☆ |
Preparations
| Preparations | Sources | Consensus |
|---|---|---|
| ethanolic extract | Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society (and other 1 sources) | ★☆☆☆☆ |
| ethanolic extract of L. fragilis (Et-LF) | Inflammopharmacology (and other 1 sources) | ★☆☆☆☆ |